BNP/CALL/ALCON AG/80/0.1/20.12.24 Stock

Warrant

DE000PN7C396

Market Closed - Deutsche Boerse AG 10:21:19 2024-05-28 am EDT
0.66 EUR -9.59% Intraday chart for BNP/CALL/ALCON AG/80/0.1/20.12.24
Current month+186.96%
1 month+153.85%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-28 0.66 -9.59%
24-05-27 0.73 +4.29%
24-05-24 0.7 -10.26%
24-05-23 0.78 0.00%
24-05-22 0.78 +23.81%

Delayed Quote Deutsche Boerse AG

Last update May 28, 2024 at 10:21 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ALCON INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN7C39
ISINDE000PN7C396
Date issued 2023-08-16
Strike 80 CHF
Maturity 2024-12-20 (206 Days)
Parity 10 : 1
Emission price 0.47
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.79
Lowest since issue 0.14
Spread 0.01
Spread %1.54%

Company Profile

Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Sector
-
More about the company

Ratings for Alcon Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Alcon Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
88.77 USD
Average target price
93.44 USD
Spread / Average Target
+5.26%
Consensus